1. Home
  2. NVS

NVS

Novartis AG

Logo Novartis AG

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Founded: 1895 Country:
Switzerland
Switzerland
Employees: N/A City: N/A
Market Cap: 192.9B IPO Year: 1991
Target Price: $114.00 AVG Volume (30 days): 1.5M
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield: 4.04% Dividend Payout Frequency: Annual
EPS: 7.10 EPS Growth: 123.97
52 Week Low/High: $92.19 - $108.78 Next Earning Date: 04-23-2024
Revenue: $46,660,000,000 Revenue Growth: 7.36%
Revenue Growth (this year): 5.2% Revenue Growth (next year): 4.02%

Share on Social Networks: